Payment Data Systems’s Subsidiary FiCentive Expands Relationship With C2Go, Inc.
Feb 09, 2016 13:30 pm UTC| Business
SAN ANTONIO, Feb. 09, 2016 -- Payment Data Systems (NASDAQ:PYDS), an integrated payment solutions provider, today announced that it has expanded its relationship with its customer C2Go, Inc. (“C2Go®”), an innovative...
MRI Interventions’ ClearPoint® Neuro Navigation System Reaches Milestone With Its 1,000th Procedure
Feb 09, 2016 13:30 pm UTC| Business
IRVINE, Calif., Feb. 09, 2016 -- MRI Interventions, Inc. (OTCQB:MRIC) today announced that its ClearPoint Neuro Navigation System was utilized for its 1,000th neurosurgical procedure. “More than one thousand patients...
SharpSpring Receives the ‘Business Impact Leader of the Year’ Award in Gainesville
Feb 09, 2016 13:30 pm UTC| Business
GAINESVILLE, Fla., Feb. 09, 2016 -- SharpSpring, Inc. (NASDAQ:SHSP), a global provider of cloud-based marketing technologies, received the “Business Impact Leader of the Year” award by the Gainesville Chamber of...
Greenlight Capital Re to Release Fourth Quarter and Year End 2015 Results
Feb 09, 2016 13:30 pm UTC| Business
GRAND CAYMAN, Cayman Islands, Feb. 09, 2016 -- Greenlight Capital Re, Ltd. (NASDAQ:GLRE), a specialist property and casualty reinsurer based in the Cayman Islands and Ireland, today announced that it expects to release...
Feb 09, 2016 13:30 pm UTC| Business
VIRGINIA BEACH, Va., Feb. 09, 2016 -- Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) (“Wheeler” or the “Company”) announced today that it will issue its financial results for the 2015 fourth quarter ended...
VBI Vaccines Announces Research Collaboration with GlaxoSmithKline to Enhance Vaccine Stability
Feb 09, 2016 13:30 pm UTC| Business
CAMBRIDGE, Mass., Feb. 09, 2016 -- VBI Vaccines Inc. (Nasdaq:VBIV) (“VBI”) has entered into a research collaboration with GlaxoSmithKline Biologicals SA (“GSK”) to evaluate VBI’s LPV™ Platform. VBI’s LPV Platform is a...
Aldeyra Therapeutics Appoints Mary Taylor, MPH as Senior Vice President, Regulatory Affairs
Feb 09, 2016 13:30 pm UTC| Business
LEXINGTON, Mass., Feb. 09, 2016 -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to aldehydes, today announced that Mary E....